1. Home

GPhC may look at overprescribing risk from IP contractors ‘in future’

 
• By James Stent

The GPhC has said that regulating overprescribing risks is a “developing area”, amid concerns about IP contractor conflicts of interest at this year’s Pharmacy Show.

Hannbeck Clark Lismore Patel
Sam Patel proposed that the pharmacy regulator keeps an “active register” of prescribing contractors
James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

More from Regulation